Headquartered in New Haven, CT,Achillion applies expertise in biology and structure-guided design and a deep understanding of patient and clinician needs to develop innovative treatment solutions aimed at improving the lives of patients. More...
Hepatitis C is a worldwide epidemic affecting more than 150 million individuals. Click to learn more about this disease.
No upcoming events at this time.
Achillion Reports 2014 Fourth Quarter and Year-End Financial Results
Achillion Pharmaceuticals Announces Closing of Public Offering of Common Stock